Difficulty: Medium
Average Score: 64%
Practice
Treatment with selegilin postpones the need for levodopa for 3-9 months and may retard the progression of Parkinson├óÔé¼┬▓s disease.
Correct answer
A
Rationale
1. Selegiline is a monoamine oxidase-B inhibitor that can delay the need for levodopa by inhibiting dopamine breakdown.
2. Studies have shown that selegiline can postpone the need for levodopa by 3-9 months.
3. By delaying levodopa initiation, selegiline may slow down the progression of Parkinson's disease.
4. Therefore, the statement that treatment with selegiline postpones the need for levodopa and may retard disease progression is true.
Summary:
B is incorrect because evidence supports the efficacy of selegiline in delaying levodopa use. C is incorrect as there is a clear correct answer. D is incorrect as not all options are correct, only option A is supported by evidence.
2. Studies have shown that selegiline can postpone the need for levodopa by 3-9 months.
3. By delaying levodopa initiation, selegiline may slow down the progression of Parkinson's disease.
4. Therefore, the statement that treatment with selegiline postpones the need for levodopa and may retard disease progression is true.
Summary:
B is incorrect because evidence supports the efficacy of selegiline in delaying levodopa use. C is incorrect as there is a clear correct answer. D is incorrect as not all options are correct, only option A is supported by evidence.